Dr. Ross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 N 39th St
Ste 515
Philadelphia, PA 19104Phone+1 215-662-8069
Education & Training
UPMC Medical EducationResidency, Ophthalmology, 2012 - 2015
Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 2011 - 2012
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2011
Certifications & Licensure
PA State Medical License 2011 - 2024
NM State Medical License 2014 - 2014- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 68 citationsGLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular HypertensionJacob Sterling, Modupe O Adetunji, Samyuktha Guttha, Albert Bargoud, Katherine E. Uyhazi
Cell Reports. 2020-11-03 - 21 citationsRescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1Ahmara G. Ross, Devin S. McDougald, Reas S. Khan, Thu T. Duong, Kimberly Dine
Gene Therapy. 2021-02-15 - 10 citationsA multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma.Shefali S Verma, Harini V Gudiseva, Venkata R M Chavali, Rebecca J Salowe, Yuki Bradford
Cell. 2024-01-18
Press Mentions
More Than 10,000 Black Philadelphians Are Participating in a Penn Study to Understand GlaucomaAugust 9th, 2021- Noveome Biotherapeutics, Inc. Announces Preliminary Results of Its Phase 1 Open Label Clinical Trial Evaluating Intranasal Delivery of Lead Candidate ST266 in Glaucoma Suspect PatientsJune 7th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
